How do you pay?

How to pay the least

Lowest posted price

from $35 a month

Tresiba from Novo Nordisk, without insurance.

  1. Sign up for Tresiba Savings Offer.Sign up on tresiba.com 

Free from the maker, if you qualify Immediate Supply. In order to redeem this offer, patient must have a valid prescription for a covered insulin and attest to being at risk of rationing insulin due to financial hardship. Or call 1-844-668-6463.

See if you qualify 

Free from the maker, if you qualify Novo Nordisk Patient Assistance Program (PAP). For all other medications, total household income must be at or below 400% of the federal poverty level. Or call 1-866-310-7549.

See if you qualify 

Tresiba is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Compare every option

Question
Brand nameTresiba
Authorized genericinsulin degludec
Regular genericinsulin degludec
What you’d pay
From$35a month with the maker’s card
Not soldThere isn’t one
Not soldNone sold yet
Same as Tresiba?
The original
–
–

Coverage: With Medicare, a month’s supply of a covered insulin costs no more than $35.

Brand nameThe maker’s card

Tresiba Savings Offer

Savings card from Novo Nordisk

No insurance · from $35 a month
Insurance · as little as $35 a prescription

Sign up on tresiba.com 

In the maker’s words

“If you have private or commercial insurance, such as insurance you receive through an employer or purchase yourself, you can pay as little as $35 or no more than $99 per prescription with the Tresiba® Savings Offer.”

“With this savings program, you may be eligible to pay $35 for a monthly supply of any combination of Novo Nordisk insulin products, up to 3 vials or 2 packs of pens (up to 35 mL) and get 1 pack of needles for $25.”

From the maker’s offer on tresiba.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s price above. You can usually use one or the other on a fill, not both.

Brand nameTrumpRx.gov price

TrumpRx.gov, the federal government’s drug price site, lists Tresiba at a price its maker agreed to, for people paying without insurance.

  • TrumpRx.gov $35FlexTouch®, 100 units/mLTrumpRx sends you to NovoCare, Novo Nordisk’s own program, to order it.

From TrumpRx.gov, read October 28, 2026. Its page opens on this price; other strengths and amounts are priced there too. With insurance, check your co-pay first: it may be lower.

Brand nameWith a free discount coupon

Optum Perks, Optum’s free discount coupon, lists these prices for Tresiba without insurance. Show the coupon from its page at the pharmacy; it can’t be used with insurance.

From Optum Perks, read November 2, 2026, with no location set. Its page opens on this dose; other doses and pharmacies near you are priced there too. With insurance, check your co-pay first: it may be lower.

Authorized genericNot sold

There isn’t one. An authorized generic is Tresiba itself, from the same company, sold without the brand name, and usually for less. For now Tresiba is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Tresiba is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

TRESIBA is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.

Limitations of Use:

  • Not recommended for the treatment of diabetic ketoacidosis.

Source: the FDA label for Tresiba (Novo Nordisk), July 1, 2022. Full label on DailyMed 

Good to know